Lemaitre Vascular Inc SEC filings LMAT

Lemaitre Vascular Inc has 1,001 filings in SEC EDGAR's recent list, going back to Jun 7, 2016. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Lemaitre Vascular Inc SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 14, 2026 —
DEF 14A Proxy statement Apr 14, 2026 Apr 13, 2026
DEFA14A Additional proxy material May 9, 2025 —
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 Jun 2, 2025
DEF 14A Proxy statement Apr 16, 2024 Jun 3, 2024
DEF 14A Proxy statement Apr 14, 2023 —
DEF 14A Proxy statement Apr 14, 2022 Jun 1, 2022
DEF 14A Proxy statement Apr 20, 2021 Jun 3, 2021
DEF 14A Proxy statement Jun 16, 2020 Jul 30, 2020
DEF 14A Proxy statement Apr 17, 2019 Jun 3, 2019
DEF 14A Proxy statement Apr 20, 2018 Jun 5, 2018
DEF 14A Proxy statement Apr 18, 2017 Jun 5, 2017

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
LMAT (Nasdaq)
Fiscal year ends
December 31
Headquarters
Burlington, MA
SEC filer status
Large accelerated filer
SEC CIK
1158895

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.